Cidara Therapeutics, Inc. Operating Margin in % from 2022 to Q1 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Cidara Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2022 to Q1 2025.
  • Cidara Therapeutics, Inc. Operating Margin for the quarter ending March 31, 2025 was -63.9K %, a 3179% decline year-over-year.
  • Cidara Therapeutics, Inc. annual Operating Margin for 2024 was -13.8K %, a 11784% decline from 2023.
  • Cidara Therapeutics, Inc. annual Operating Margin for 2023 was -116 %, a 124% decline from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)

Cidara Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 -63.9K -65.9K -3179% Jan 1, 2025 Mar 31, 2025
Q4 2024 -13.8K -13.7K -11784% Oct 1, 2024 Dec 31, 2024
Q3 2024 886 +930 Jul 1, 2024 Sep 30, 2024
Q2 2024 1.92K +1.93K Apr 1, 2024 Jun 30, 2024
Q1 2024 2.07K +2.09K Jan 1, 2024 Mar 31, 2024
Q4 2023 -116 -64.2 -124% Oct 1, 2023 Dec 31, 2023
Q3 2023 -43.3 Jul 1, 2023 Sep 30, 2023
Q2 2023 -3.97 Apr 1, 2023 Jun 30, 2023
Q1 2023 -14.7 Jan 1, 2023 Mar 31, 2023
Q4 2022 -52 Oct 1, 2022 Dec 31, 2022

Cidara Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -13.8K -13.7K -11784% Jan 1, 2024 Dec 31, 2024
2023 -116 -64.2 -124% Jan 1, 2023 Dec 31, 2023
2022 -52 Jan 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.